The ROE as of November 2024 (TTM) for Fortress Biotech, Inc. (FBIO) is -240.30%

According to Fortress Biotech, Inc.’s latest financial reports and current stock price. The company's current ROE is -240.30%. This represents a change of 300.12% compared to the average of -60.06% of the last 4 quarters.

Fortress Biotech, Inc. (FBIO) Historical ROE (quarterly & annually)

How has FBIO ROE performed in the past?

The mean historical ROE of Fortress Biotech, Inc. over the last ten years is -616.16%. The current -240.30% ROE has changed -61.00% with respect to the historical average. Over the past ten years (40 quarters), FBIO's ROE was at its highest in in the March 2019 quarter at 6.69%. The ROE was at its lowest in in the December 2018 quarter at -1343.41%.

Fortress Biotech, Inc. (FBIO) ROE by Quarter and Year

Discovering the peaks and valleys of Fortress Biotech, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Fortress Biotech, Inc. (FBIO) Average ROE

How has FBIO ROE performed in the past?

The current ROE of Fortress Biotech, Inc. (FBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Fortress Biotech, Inc. (FBIO) ROE vs. Peers

How is FBIO’s ROE compared to its peers?

Fortress Biotech, Inc.’s ROE is less than Mustang Bio, Inc. (429.53%), greater than Achilles Therapeutics plc (-54.57%), less than Aptose Biosciences Inc. (1.03%), greater than Fortress Biotech, Inc. (-240.30%), less than Checkpoint Therapeutics, Inc. (359.97%), greater than Avenue Therapeutics, Inc. (-473.61%), greater than Pieris Pharmaceuticals, Inc. (-76.24%), greater than Aileron Therapeutics, Inc. (-46.89%), less than Reviva Pharmaceuticals Holdings, Inc. (664.92%), greater than Eyenovia, Inc. (-1243.79%), greater than Cognition Therapeutics, Inc. (-150.93%), greater than TransCode Therapeutics, Inc. (-649.01%), greater than Kodiak Sciences Inc. (-84.52%), greater than XOMA Corporation (-33.68%), less than ZIVO Bioscience, Inc. (618.61%), greater than Lumos Pharma, Inc. (-233.03%), less than Reviva Pharmaceuticals Holdings, Inc. (664.92%), greater than Athira Pharma, Inc. (-115.63%), less than ACADIA Pharmaceuticals Inc. (25.83%), greater than Cabaletta Bio, Inc. (-50.10%),

Build a custom stock screener for Fortress Biotech, Inc. (FBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fortress Biotech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fortress Biotech, Inc. (FBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fortress Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.